ClinicalTrials.Veeva

Menu

Effect of Diclofenac Sodium Versus Calcium Hydroxide as Intracanal Medication on the Intensity of Postoperative Pain, Bacterial Load Reduction and MMP-9 Levels in Patients With Necrotic Pulp.

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Not yet enrolling
Early Phase 1

Conditions

Apical Periodontitis
Necrotic Pulp

Treatments

Drug: Diclofenac Sodium

Study type

Interventional

Funder types

Other

Identifiers

NCT05582421
1141821228

Details and patient eligibility

About

the aim of this study is to compare the effect of using Diclofenac Sodium Versus Calcium Hydroxide as Intracanal medication on intensity of postoperative pain, bacterial load reduction after root canal preparation and periapical matrix metalloproteinase 9 level (MMP-9) post-instrumentation and pre-obturation in teeth with necrotic pulp

Full description

To compare the effect of diclofenac sodium versus calcium hydroxide as intra canal medication on:

  • Primary Outcome Intensity of postoperative pain will be measured using numerical rating scale (NRS) at 6, 12, 24 and 48- hours post-instrumentation and at 6, 12, 24 and 48 hours post-obturation.

Secondary Outcome 1 Bacterial load reduction will be determined by bacterial counting using agar culture technique after root canal preparation (CFU/ml).

Secondary Outcome 2 Periapical MMP-9 level will be determined post-instrumentation and pre-obturation by ELISA.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Inclusion criteria:

  • Patients who are free from any physical or mental handicapping condition with no underlying systemic disease.

  • Age between 18-50 years.

  • Males & Females.

  • Mandibular single rooted permanent premolar teeth:

    • Diagnosed clinically with pulp necrosis.
    • Absence of spontaneous pain.
    • Positive pain on percussion denoting apical periodontitis.
    • Slight widening in the periodontal membrane space or with periapical radiolucency not exceeding 2*2 mm radiographically.
  • Patients' acceptance to participate in the trial.

  • Patients who can understand pain scale and can sign the informed consent

Exclusion criteria

  • Medically compromised patients
  • Pregnant women.
  • If analgesics or antibiotics have been administrated by the patient during the past 24 hours preoperatively.
  • Patients reporting bruxism or clenching.
  • Teeth that show association with acute periapical abscess and swelling.
  • Greater than grade I mobility or pocket depth greater than 5mm.
  • Non-restorable teeth
  • Teeth with vital pulp.
  • Immature teeth.
  • Radiographic evidence of external or internal root resorption vertical root fracture, perforation, calcification.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 2 patient groups

calcium hydroxide
Sham Comparator group
Description:
calcium hydroxide will be placed as intracanal medication between visits.
Treatment:
Drug: Diclofenac Sodium
diclofenac sodium
Active Comparator group
Description:
diclofenac sodium will be placed as intracanal medication between visits
Treatment:
Drug: Diclofenac Sodium

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems